Putative neurotrophic factors and functional recovery from peripheral nerve damage in the rat
- PMID: 1678980
- PMCID: PMC1908108
- DOI: 10.1111/j.1476-5381.1991.tb12297.x
Putative neurotrophic factors and functional recovery from peripheral nerve damage in the rat
Abstract
1. In rats, recovery of sensory-motor function following a crush lesion of the sciatic or tibial nerve was monitored by measuring foot reflex withdrawal from a local noxious stimulation of the foot sole. 2. Putative neurotrophic compounds were tested on this functional recovery model: melanocortins (peptides derived from ACTH (corticotropin) and alpha-MSH (melanotropin], gangliosides and nimodipine were effective whereas isaxonine and TRH (thyrotropin releasing hormone) were not. 3. Structure-activity studies with melanocortins revealed a similar effectiveness of alpha-MSH, [N-Leu4, D-Phe7]-alpha-MSH, desacetyl-alpha-MSH and the ACTH analogue ORG 2766, questioning the validity of the previously suggested notion that the melanotrophic properties of these peptides are responsible for their neurotrophic effect. 4. As recovery of function after peripheral nerve damage follows a similar time course in hypophysectomized (five days post operation) and sham-operated rats, effective melanocortin therapy does not mimic an endogenous peptide signal in the repair process from pituitary origin. 5. Subcutaneous treatment with ORG 2766 (7.5 micrograms kg-1 48 h-1) facilitates recovery of function following peripheral nerve damage in young (6-7 weeks old), mature (5 month old) and old (20 month old) rats. 6. In view of the diversity in structure of the effective neurotrophic factors and the complexity of nerve repair, the present data support the notion that peripheral nerve repair may be facilitated by different humoral factors likely to be active on different aspects of the recovery process.
Similar articles
-
alpha-MSH and Org.2766 in peripheral nerve regeneration: different routes of delivery.Eur J Pharmacol. 1988 Mar 15;147(3):351-7. doi: 10.1016/0014-2999(88)90168-9. Eur J Pharmacol. 1988. PMID: 2837394
-
Pharmacological aspects of the influence of melanocortins on the formation of regenerative peripheral nerve sprouts.Peptides. 1987 Jul-Aug;8(4):581-4. doi: 10.1016/0196-9781(87)90028-3. Peptides. 1987. PMID: 2819831
-
Org.2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat.Peptides. 1987 May-Jun;8(3):415-22. doi: 10.1016/0196-9781(87)90003-9. Peptides. 1987. PMID: 2821519
-
Neurotrophic effects of ACTH/MSH neuropeptides.Acta Neurobiol Exp (Wars). 1990;50(4-5):353-66. Acta Neurobiol Exp (Wars). 1990. PMID: 1966658 Review.
-
Melanotropins as growth factors.Ann N Y Acad Sci. 1993 May 31;680:29-50. doi: 10.1111/j.1749-6632.1993.tb19673.x. Ann N Y Acad Sci. 1993. PMID: 8390155 Review.
Cited by
-
Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.Br J Pharmacol. 1993 Mar;108(3):780-5. doi: 10.1111/j.1476-5381.1993.tb12878.x. Br J Pharmacol. 1993. PMID: 8467365 Free PMC article.
-
Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.Br J Pharmacol. 1993 Dec;110(4):1335-40. doi: 10.1111/j.1476-5381.1993.tb13965.x. Br J Pharmacol. 1993. PMID: 8306072 Free PMC article.
-
Conditional deletion of the Itgb4 integrin gene in Schwann cells leads to delayed peripheral nerve regeneration.J Neurosci. 2008 Oct 29;28(44):11292-303. doi: 10.1523/JNEUROSCI.3068-08.2008. J Neurosci. 2008. PMID: 18971471 Free PMC article.
-
Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.Br J Pharmacol. 1994 Mar;111(3):887-93. doi: 10.1111/j.1476-5381.1994.tb14821.x. Br J Pharmacol. 1994. PMID: 8019766 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials